SAT-001 Clinically Meaningful Effects of E2/P4 Oral Capsule in Treating Vasomotor Symptoms

類似資料

• Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms
  著者:: Constantine, Ginger D., 等
  出版事項: (2019)
• SAT-021 Effects of E2/P4 Oral Capsules on Bone Turnover in Women with Vasomotor Symptoms
  著者:: Constantine, Ginger, 等
  出版事項: (2020)
• SAT-237 Combined Bioidentical Estradiol and Progesterone Capsules Improved Quality of Sleep in Postmenopausal Women with Vasomotor Symptoms
  著者:: Santoro, Nanette, 等
  出版事項: (2019)
• SAT-238 Predictors Of Vaginal/Uterine Bleeding With Oral TX-001HR (Estradiol and Progesterone) Capsules Taken For Menopausal Vasomotor Symptoms
  著者:: Constantine, Ginger, 等
  出版事項: (2019)
• TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial
  著者:: Constantine, Ginger D., 等
  出版事項: (2020)